Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04002167 · ClinicalTrials.gov registry record · NA

A Novel fNIRS Neurofeedback Intervention for Enhancement of Working Memory in Attention Deficit Hyperactivity Disorder (ADHD)

A NA study of ADHD, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
65
Enrollment target
1
Study location

NCT04002167 is a NA study of ADHD that has completed, run by Stanford University. The registered enrollment target is 65 participants, below the 189-participant average among 75 other ADHD trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04002167, a NA study of ADHD, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
65 participants
Enrollment target
1
Study location

Study Summary

The proposed study is to test and validate a novel intervention that integrates computerized cognitive training with real-time neuromonitoring and neurofeedback to enhance working memory by probing the individualized neural systems underlying working memory. We will test the proposed intervention on children with ADHD with working memory deficits. The R61 proof-of-concept phase will assess the target engagement, effective dose and feasibility.

Conditions Studied

Interventions

  • BEHAVIORAL Neurofeedback
  • BEHAVIORAL Cognitive training

Study Locations (1)

California

  • Stanford University School of Medicine - Stanford

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2019-08-16
Est. Completion 2022-09-14
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT04002167

The ClinicalTrials.gov registry entry for NCT04002167 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 189-participant average among 75 other ADHD trials with a reported enrollment target (66% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with ADHD appearing as the primary indexed condition, and to 2 interventions - of which Neurofeedback is the first listed.

NCT04002167 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04002167 about?

NCT04002167 is a clinical study titled "A Novel fNIRS Neurofeedback Intervention for Enhancement of Working Memory in Attention Deficit Hyperactivity Disorder (ADHD)". The proposed study is to test and validate a novel intervention that integrates computerized cognitive training with real-time neuromonitoring and neurofeedback to enhance working memory by probing the individualized neural systems underlying working memory. We will test the proposed intervention on...

What is the current status of trial NCT04002167?

This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2019-08-16. Estimated completion is 2022-09-14.

What conditions does trial NCT04002167 study?

This clinical trial studies the following conditions: ADHD.

What interventions are being tested in trial NCT04002167?

The interventions under investigation include: Neurofeedback (BEHAVIORAL), Cognitive training (BEHAVIORAL).

Who is sponsoring clinical trial NCT04002167?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04002167 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for ADHD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.